(Total Views: 335)
Posted On: 10/26/2021 12:15:50 PM
Post# of 62

$HGEN News Article - First Patient Dosed in Phase 2 Precision Medicine Study of Lenzilumab in Patients with Chronic Myelomonocytic Leukemia (CMML) https://marketwirenews.com/news-releases/firs...40533.html


My Twitter: WhyteStocks